- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ ↓ -0.74%
NAV chart
SMA (Simple Moving Average)
- 50 SMA
- 100 SMA
- 200 SMA
- 400 SMA
Returns
CAGR returns till date
CAGR returns of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth and its peers as on 13 February, 2026| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|---|---|---|---|---|---|---|---|---|---|
| Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth | -0.59% | -0.74% | 1.29% | -0.82% | -2.18% | 7.18% | 23.82% | 14.92% | - | - |
| SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH | -3.44% | -1.05% | 0.6% | -1.55% | -4.72% | 1.29% | 13.92% | 16.69% | 16.2% | 16.86% |
| SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth | -1.92% | -0.96% | -0.17% | -0.93% | -1.11% | 10.24% | 14.69% | 12.18% | 14.56% | 14.93% |
| SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH | -0.71% | -1.01% | 1.53% | -0.77% | -3.47% | 3.79% | 25.54% | 16.87% | 21.41% | 13.46% |
| SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH | -1.43% | -1.21% | -0.35% | 1.76% | -1.33% | 8.93% | 22.39% | 21.1% | 21.08% | 18.32% |
| SBI PSU Fund - DIRECT PLAN - GROWTH | 5.59% | -1.19% | 1.43% | 5.81% | 6.15% | 30.1% | 35.14% | 29.88% | 23.35% | 18.01% |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | - | - | - | - | 57.54% | 20.14% | -11.24% | 40.42% | 37.69% | -3.36% |
Discrete returns (monthly)
| Month | Apr 2025 | May 2025 | Jun 2025 | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | 3.66% | -0.46% | 3.21% | 3.96% | -0.38% | -1.79% | 1.3% | 0.44% | -1.25% | -3.8% |
Returns from spefic dates
| Description | CAGR returns from 18 Oct 2021 (Nifty 50 2021 high) | CAGR returns from 26 Sep 2024 (Nifty 50 2024 high) |
|---|---|---|
| Returns | 12.07% | -2.66% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|---|---|---|---|
| 96.74% | 0.00% (Arbitrage: 0.00%) | 0.00% | 0.00% | 3.26% |
Equity
| Name | Symbol / ISIN | Sector | Weight % |
|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 11.60% |
| Apollo Hospitals Enterprise Limited | APOLLOHOSP (INE437A01024) | Healthcare Services | 7.70% |
| Cipla Limited | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 6.68% |
| Fortis Healthcare Limited | FORTIS (INE061F01013) | Healthcare Services | 4.56% |
| Lupin Limited | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 4.55% |
| Abbott India Limited | ABBOTINDIA (INE358A01014) | Pharmaceuticals & Biotechnology | 4.43% |
| Torrent Pharmaceuticals Limited | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 4.30% |
| Ajanta Pharmaceuticals Limited | AJANTPHARM (INE031B01049) | Pharmaceuticals & Biotechnology | 3.76% |
| IPCA Laboratories Limited | IPCALAB (INE571A01038) | Pharmaceuticals & Biotechnology | 3.30% |
| Aurobindo Pharma Limited | AUROPHARMA (INE406A01037) | Pharmaceuticals & Biotechnology | 2.97% |
| Mankind Pharma Ltd | MANKIND (INE634S01028) | Pharmaceuticals & Biotechnology | 2.83% |
| J.B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM (INE572A01036) | Pharmaceuticals & Biotechnology | 2.80% |
| Emcure Pharmaceuticals Ltd | EMCURE (INE168P01015) | Pharmaceuticals & Biotechnology | 2.77% |
| Jupiter Life Line Hospitals Ltd | JLHL (INE682M01012) | Healthcare Services | 2.46% |
| Thyrocare Technologies Limited | THYROCARE (INE594H01019) | Healthcare Services | 2.28% |
| Alkem Laboratories Limited | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 2.28% |
| Divi's Laboratories Limited | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 2.07% |
| SAI Life Sciences Ltd | SAILIFE (INE570L01029) | Pharmaceuticals & Biotechnology | 2.00% |
| ALEMBIC PHARMACEUTICALS LIMITED | APLLTD (INE901L01018) | Pharmaceuticals & Biotechnology | 1.96% |
| Shilpa Medicare Ltd | SHILPAMED (INE790G01031) | Pharmaceuticals & Biotechnology | 1.78% |
| Medi Assist Healthcare Services Ltd | MEDIASSIST (INE456Z01021) | Insurance | 1.76% |
| METROPOLIS HEALTHCARE LIMITED | METROPOLIS (INE112L01020) | Healthcare Services | 1.56% |
| ANTHEM BIOSCIENCES LIMITED | ANTHEM (INE0CZ201020) | Pharmaceuticals & Biotechnology | 1.55% |
| Dr. Reddys Laboratories Limited | DRREDDY (INE089A01031) | Pharmaceuticals & Biotechnology | 1.40% |
| Procter & Gamble Health Limited | PGHL (INE199A01012) | Pharmaceuticals & Biotechnology | 1.38% |
| GlaxoSmithKline Pharmaceuticals Limited | GLAXO (INE159A01016) | Pharmaceuticals & Biotechnology | 1.27% |
| Suraksha Diagnostic Ltd | SURAKSHA (INE877V01027) | Healthcare Services | 1.26% |
| Jubilant Pharmova Ltd | JUBLPHARMA (INE700A01033) | Pharmaceuticals & Biotechnology | 1.23% |
| Biocon Limited | BIOCON (INE376G01013) | Pharmaceuticals & Biotechnology | 1.19% |
| Gland Pharma Limited | GLAND (INE068V01023) | Pharmaceuticals & Biotechnology | 1.14% |
| SANOFI CONSUMER HEALTHCARE | SANOFICONR (INE0UOS01011) | Pharmaceuticals & Biotechnology | 1.09% |
| Piramal Pharma Ltd | PPLPHARMA (INE0DK501011) | Pharmaceuticals & Biotechnology | 1.04% |
| Pfizer Limited | PFIZER (INE182A01018) | Pharmaceuticals & Biotechnology | 1.01% |
| Max Healthcare Institute Limited | MAXHEALTH (INE027H01010) | Healthcare Services | 0.95% |
| Vinati Organics Limited | VINATIORGA (INE410B01037) | Chemicals & Petrochemicals | 0.92% |
| Vijaya Diagnostic Centre Limited | VIJAYA (INE043W01024) | Healthcare Services | 0.91% |
Portfolio data is as on date 31 October, 2025
NAV history
Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth - 30 days NAV (Net asset value) history
| Date | NAV |
|---|---|
| 13 February, 2026 | 33.73 |
| 12 February, 2026 | 33.98 |
| 11 February, 2026 | 34.06 |
| 10 February, 2026 | 33.86 |
| 9 February, 2026 | 33.81 |
| 6 February, 2026 | 33.3 |
| 5 February, 2026 | 33.33 |
| 4 February, 2026 | 33.33 |
| 3 February, 2026 | 33.46 |
| 2 February, 2026 | 32.64 |
| 30 January, 2026 | 32.86 |
| 29 January, 2026 | 32.36 |
| 28 January, 2026 | 32.65 |
| 27 January, 2026 | 32.64 |
| 23 January, 2026 | 32.61 |
| 22 January, 2026 | 32.99 |
| 21 January, 2026 | 32.74 |
| 20 January, 2026 | 32.89 |
| 19 January, 2026 | 33.52 |
| 16 January, 2026 | 33.67 |
| 14 January, 2026 | 33.99 |
| 13 January, 2026 | 34.01 |
| 12 January, 2026 | 33.99 |
| 9 January, 2026 | 34.18 |
| 8 January, 2026 | 34.5 |
| 7 January, 2026 | 34.92 |
| 6 January, 2026 | 34.71 |
| 5 January, 2026 | 34.25 |
| 2 January, 2026 | 34.23 |
| 1 January, 2026 | 33.93 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth?
The latest NAV of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth is 33.73 as on 13 February, 2026.What are YTD (year to date) returns of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth?
The YTD (year to date) returns of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth are -0.59% as on 13 February, 2026.What are 1 year returns of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth?
The 1 year returns of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth are 7.18% as on 13 February, 2026.What are 3 year CAGR returns of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth?
The 3 year annualized returns (CAGR) of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth are 23.82% as on 13 February, 2026.What are 5 year CAGR returns of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth?
The 5 year annualized returns (CAGR) of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth are 14.92% as on 13 February, 2026.